PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

NYU Langone awarded $1.6 million to investigate Alzheimer’s & Parkinson’s progression through the eye

NYU Langone awarded $1.6 million to investigate Alzheimer’s & Parkinson’s progression through the eye
2024-10-02
Researchers at NYU Langone Health were awarded $1.6 million from the National Institutes of Health (NIH) to investigate changes in the eye that may indicate early signs of Alzheimer’s disease and Parkinson’s disease. The award, OT2OD038130, recognizes the eye as a part of the brain and its role as a window into cognitive and visual health. After the initial $1.6 million award, the grant may renew an additional two years, for a total of $4.8 million as part of the NIH Common Fund Venture Program’s new Oculomics Initiative. Oculomics is a relatively new term to describe the integrative use of technology and ...

Missing link found in gamma emission phenomena from thunderclouds

Missing link found in gamma emission phenomena from thunderclouds
2024-10-02
Groundbreaking Discoveries in Gamma-Ray Emissions from Thunderstorms In the recent edition of Nature, groundbreaking results about the gamma-ray emissions produced during thunderstorms are presented. Overall, these findings reveal that gamma-ray emission from thunderclouds is much more complex, diverse, and dynamic than previously thought. Understanding these phenomena is crucial to uncovering the secrets of lightning. Flickering Gamma-Ray Flashes: A New Discovery Entitled “Flickering Gamma-Ray Flashes, the Missing Link between Gamma Glows and TGFs,” the paper by Østgaard et al. [2024] reports unique observations of a new phenomenon called Flickering Gamma-Ray ...

Social media users’ actions, rather than biased policies, could drive differences in platform enforcement

2024-10-02
A new paper, “Differences in misinformation sharing can lead to politically asymmetric sanctions,” published today in Nature suggests that the higher quantity of social media policy enforcement (such as account suspensions) for conservative users could be explained by the higher quantity of misinformation shared by those conservative users — and so does not constitute evidence of inherent biases in the policies from social media companies or in the definition of what constitutes misinformation.  Written by ...

How a bacterium becomes a permanent resident in a fungus

2024-10-02
Endosymbiosis is a fascinating biological phenomenon in which an organism lives inside another. Such an unusual relationship is often beneficial for both parties. Even in our bodies, we find remnants of such cohabitation: mitochondria, the powerhouses of our cells, evolved from an ancient endosymbiosis. Long ago, bacteria entered other cells and stayed. This coexistence laid the foundation for mitochondria and thus the cells of plants, animals, and fungi. What is still poorly understood, however, is how an endosymbiosis as a lifestyle actually arises. A bacterium that more or less accidentally ...

Study: For long COVID, lithium aspartate at low doses is ineffective, but higher doses may be promising

2024-10-02
BUFFALO, N.Y. — A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID; however, a supplemental dose-finding study found some evidence that higher doses may be effective. Published in JAMA Network Open on Oct. 2, the study was led by Thomas J. Guttuso, Jr., MD, professor of neurology in the Jacobs School of Medicine and Biomedical Sciences at UB and a physician with UBMD Neurology. “It’s a negative study with a positive twist,” Guttuso concludes. Because ...

Online insomnia treatment can help caregivers get much-needed rest, study suggests

Online insomnia treatment can help caregivers get much-needed rest, study suggests
2024-10-02
Providing care for a family member with a disabling illness can be a demanding job that leaves many people unable to sleep, but an online insomnia treatment developed at the University of Virginia School of Medicine can help, new research shows. Not only did the SHUTi (Sleep Healthy Using the Internet) sleep intervention help caregivers get better rest, it most benefited those shouldering the greatest responsibilities in caring for their loved ones, the researchers found.  The results suggest the online format of the program ...

Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies

Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
2024-10-02
Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies The company is developing the biomaterial-based technology to develop novel therapies able to program anti-cancer immunity and prevent infectious diseases By Benjamin Boettner (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Attivare Therapeutics Inc. announced that Attivare has licensed a portfolio of immune-modulating biomaterial technologies from Harvard University that was created at the ...

Regenstrief, Fairbanks researcher among 25 fellows to be inducted into American College of Medical Informatics

2024-10-02
The American College of Medical Informatics (ACMI) has announced that Chris Harle, PhD, of the Indiana University Richard M. Fairbanks School of Public Health and the Regenstrief Institute will be inducted as one of 25 new fellows on November 10 in San Francisco, CA, at ceremonies during the American Medical Informatics Association (AMIA) 2024 Annual Symposium. ACMI is a college of elected fellows who have made significant and sustained contributions to the field of biomedical informatics. Individuals who have achieved national recognition in the field and are committed to advancing ...

Ontario Institute for Cancer Research funding aims to speed the development of new drugs for some of the most common cancers

2024-10-02
October 2, 2024, TORONTO – The Ontario Institute for Cancer Research (OICR) continues to support Ontario drug discovery research by funding high-quality investigations of new therapies for some of the most prevalent pediatric and adult cancers. These projects are tackling substantial challenges in cancer by increasing the effectiveness and availability of immunotherapies, making cancer more vulnerable to chemotherapy and developing a new drug for one of the deadliest forms of childhood brain cancer. OICR’s Cancer Therapeutics Innovation Pipeline (CTIP) initiative is supporting three research teams ...

Trust in US Supreme Court continues to sink

Trust in US Supreme Court continues to sink
2024-10-02
PHILADELPHIA – Driven by political partisanship, public trust in the U.S. Supreme Court has continued a downward slide since the court’s 2022 Dobbs decision overturning the Roe v. Wade ruling that established a constitutional right to abortion, according to a new survey by the Annenberg Public Policy Center (APPC) of the University of Pennsylvania. More than half of Americans (56%) now disapprove of the Supreme Court, saying they trust it either “a little” or “not at all” to act in the best interest ...

Rice’s Biotech Launch Pad to lead commercialization of bioelectrical implant treatment for obesity, type 2 diabetes

Rice’s Biotech Launch Pad to lead commercialization of bioelectrical implant treatment for obesity, type 2 diabetes
2024-10-02
Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs. Rice University’s Biotech Launch Pad will lead the commercialization effort for “Rx On-site Generation Using Electronics” (ROGUE), a self-contained, durable implantable device that houses cells engineered ...

Carnegie Mellon to lead development of implantable cell-based bioelectronic devices for patient-specific treatment and disease monitoring

Carnegie Mellon to lead development of implantable cell-based bioelectronic devices for patient-specific treatment and disease monitoring
2024-10-02
PITTSBURGH – A Carnegie Mellon University-led team has secured an award of up to $42 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of implantable, cell-based bioelectronic devices that deliver patient-specific therapy and monitor disease status, for conditions like hypo- and hyperthyroidism, in real time. This award is part of the ARPA-H REACT program, which supports the advancement of implantable bioelectronic devices to improve patient management of chronic diseases. Burak ...

Case Western Reserve, Vanderbilt universities to develop incisionless prostate surgery using MRI and robotics

Case Western Reserve, Vanderbilt universities to develop incisionless prostate surgery using MRI and robotics
2024-10-02
CLEVELAND—Researchers at Case Western Reserve University and Vanderbilt University are pioneering a new approach to prostate cancer surgery by combining advanced robotics and “low-field” MRI technology. The research aims to allow highly accurate, patient-tailored prostate cancer surgeries without the need for traditional incisions. This innovative research marks a major step in developing minimally invasive treatments for prostate cancer, with the potential to improve both safety and efficiency for patients. The project is being funded by a new five-year, $3.7 million grant from the National Cancer Institute, part of the ...

Carnegie Mellon University secures ARPA-H award to improve adherence, lower cost of treatment for obesity and Type 2 diabetes patients

Carnegie Mellon University secures ARPA-H award to improve adherence, lower cost of treatment for obesity and Type 2 diabetes patients
2024-10-02
PITTSBURGH – A Carnegie Mellon University-led team of researchers has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H). The funds will fast track a bioelectronic implant that could radically improve treatment options and significantly reduce the cost of care for patients with obesity and Type 2 diabetes. The award will drive the accelerated development and testing of “Rx On-site Generation Using Electronics (ROGUE),” a bioelectrical device that hosts a “living pharmacy,” consisting of engineered cells that produce biological therapy to treat Type 2 diabetes and obesity. The device will offer continuous, ...

A new injectable to prevent and treat hypoglycemia

A new injectable to prevent and treat hypoglycemia
2024-10-02
People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low — from taking too much insulin or not eating enough sugar — people can experience hypoglycemia, which can lead to dizziness, cognitive impairment, seizures or comas. To prevent and treat this condition, researchers in ACS Central Science report encapsulating the hormone glucagon. In mouse trials, the nanocapsules activated when blood sugar levels dropped dangerously low and quickly restored glucose levels. Glucagon is a hormone that signals the liver to ...

Turning plants into workout supplement bio-factories

2024-10-02
It’s important to eat your veggies, but some essential vitamins and nutrients can only be found in animals, including certain amino acids and peptides. But, in a proof-of-concept study published in ACS’ Journal of Agricultural and Food Chemistry, researchers developed a method to produce creatine, carnosine and taurine — all animal-based nutrients and common workout supplements — right inside a plant. The system allows for different synthetic modules to be easily stacked together to boost production. Plants can be surprisingly receptive when asked to produce compounds ...

Pablo Manavella appointed next Editor-In-Chief of The Plant Cell

Pablo Manavella appointed next Editor-In-Chief of The Plant Cell
2024-10-02
The American Society of Plant Biologists (ASPB) is excited to announce Pablo Manavella will serve as the next Editor-in-Chief of The Plant Cell. The Plant Cell is a leading international society journal that publishes novel research of special significance in plant biology, especially in the areas of cellular biology, molecular biology, biochemistry, genetics, development, and evolution. Manavella is currently a Consejo Superior de Investigaciones Científicas (CSIC) researcher at the Institute for Mediterranean and Subtropical Horticulture (IHSM) in Málaga, Spain. He is the Principal Investigator in a lab focusing on the intricate mechanisms regulating ...

Unveiling genetic insights: how PAI-1 polymorphisms influence COVID-19 outcomes

Unveiling genetic insights: how PAI-1 polymorphisms influence COVID-19 outcomes
2024-10-02
Despite global vaccination efforts, COVID-19 continues to pose significant risks, leading to severe complications and fatalities. These risks are driven by disrupted coagulation, impaired fibrinolysis, which is the process of breaking blood clots, and heightened inflammatory responses. The fibrinolytic system, crucial for maintaining balance within the coagulation cascade, relies on plasmin-mediated fibrin degradation. Plasminogen activators convert plasminogen into plasmin, an enzyme that breaks down ...

Redefining Publishing: PLOS receives multi-million-dollar grant funding for new research initiative

2024-10-02
SAN FRANCISCO —PLOS today announced that it has received a $1.5 million grant from the Robert Wood Johnson Foundation and a $1 million grant from the Gordon and Betty Moore Foundation to support our mission to drive Open Science forward with meaningful change in scholarly publishing. The funds enable PLOS to embark on an ambitious 18-month research and design project to explore how to tackle two barriers that exclude many researchers from meaningfully participating in Open Science: affordability ...

Planning a drug’s route in the body with synthetic chemistry

2024-10-02
Researchers at the RIKEN Cluster for Pioneering Research (CPR) have developed technology that can alter, within the body, the recognized identity of proteins. The innovation, published in Nature Communications on October 2, allowed researchers to target mouse tumors with a protein and then transport that protein out of the body. This means that cancer-killing drugs could be sent directly to tumors and then excreted from the body after dropping off their payload. The technology also has the potential to allow multi-purpose drugs that can travel from organ to organ, performing ...

Smoke from megafires puts orchard trees at risk

2024-10-02
Smoke From Megafires Puts Orchard Trees at Risk Effects Last Months, Reducing Nut Crop Yields By Amy Quinton | October 2, 2023 Long-term smoke exposure from massive wildfires lowers the energy reserves of orchard trees and can cut their nut production by half, researchers at the University of California, Davis, found. The smoke can affect trees for months after a megafire, depressing their bloom and the next season’s harvest. This finding reveals a new danger from wildfires that could affect plant health in both agricultural and natural environments. Nature Plants published ...

Health Data Research UK and National Research Foundation Singapore formalize landmark partnership in health data science

2024-10-02
Health Data Research UK (HDR UK) and the National Research Foundation Singapore (NRF) are pleased to have signed a Memorandum of Understanding (MoU) today, that formalises a collaborative partnership in healthcare and data science. The partnership will leverage cutting-edge data science and research, with a focus on trustworthy data use to power improvements in healthcare, research and innovation, strengthening existing links between the UK and Singapore. The MoU was signed by Permanent Secretary for National Research and ...

CNIO researchers propose a new treatment for brain metastasis based on immunotherapy

CNIO researchers propose a new treatment for brain metastasis based on immunotherapy
2024-10-02
CNIO researchers have discovered that cancer perverts certain brain cells, the astrocytes, and causes them to produce a protein that works in favour of the tumour.   A drug, silibinin, inhibits this protein, and could be used to help treat brain metastasis with immunotherapy. A clinical trial is underway.   The work is published in the American Association for Cancer Research's journal Cancer Discovery.   Researchers at the Spanish National Cancer Research Centre (CNIO) propose a new treatment for brain metastases that respond poorly, or not at all, to immunotherapy, and provide a biomarker to predict ...

Discovery of promising electrolyte for all-solid-state batteries

Discovery of promising electrolyte for all-solid-state batteries
2024-10-02
Often overlooked, rechargeable batteries play an important part in contemporary life, powering small devices like smartphones to larger ones like electric vehicles. The keys to creating sustainable rechargeable batteries include having them hold their charge longer, giving them a longer life with more charging cycles, and making them safer. Which is why there is so much promise in all-solid-state batteries. The problem so far is discovering which solid electrolytes offer such potential advantages. In a step toward that goal, an Osaka Metropolitan University research group led by Assistant Professor Kota Motohashi, Associate Professor Atsushi Sakuda, ...

One-minute phone breaks could help keep students more focused in class and better in tests

2024-10-02
Phones can be useful tools in classrooms to remind students of deadlines or encourage more exchange between students and teachers. At the same time, they can be distracting: Students report using their phones for non-academic purposes as often as 10 times a day. Thus, in many classrooms, phones are not allowed.   Now, researchers in the US have investigated if letting students use their phones for very brief amounts of time – dubbed phone or technology breaks – can enhance classroom performance and reduce phone use. “We show that technology breaks may be helpful for reducing cell phone use in the college classroom,” said Prof Ryan Redner, a ...
Previous
Site 147 from 8067
Next
[1] ... [139] [140] [141] [142] [143] [144] [145] [146] 147 [148] [149] [150] [151] [152] [153] [154] [155] ... [8067]

Press-News.org - Free Press Release Distribution service.